GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Signify Health Inc (NYSE:SGFY) » Definitions » Debt-to-Equity

Signify Health (Signify Health) Debt-to-Equity : 0.58 (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Signify Health Debt-to-Equity?

Signify Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $3.5 Mil. Signify Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $358.6 Mil. Signify Health's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $627.4 Mil. Signify Health's debt to equity for the quarter that ended in Dec. 2022 was 0.58.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Signify Health's Debt-to-Equity or its related term are showing as below:

SGFY' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.28   Med: 0.45   Max: 0.88
Current: 0.58

During the past 5 years, the highest Debt-to-Equity Ratio of Signify Health was 0.88. The lowest was 0.28. And the median was 0.45.

SGFY's Debt-to-Equity is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.49 vs SGFY: 0.58

Signify Health Debt-to-Equity Historical Data

The historical data trend for Signify Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Signify Health Debt-to-Equity Chart

Signify Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
0.88 0.28 0.45 0.30 0.58

Signify Health Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.31 0.45 0.55 0.58

Competitive Comparison of Signify Health's Debt-to-Equity

For the Health Information Services subindustry, Signify Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Signify Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Signify Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Signify Health's Debt-to-Equity falls into.



Signify Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Signify Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Signify Health's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Signify Health  (NYSE:SGFY) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Signify Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Signify Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Signify Health (Signify Health) Business Description

Traded in Other Exchanges
N/A
Address
800 Connecticut Avenue, 3rd Floor, Norwalk, CT, USA, 06854
Signify Health Inc is a healthcare technology company that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. The customers include health plans, governments, employers, health systems and physician groups. Its operating segment includes Home and Community Services and Episodes of Care Services. The company generates maximum revenue from the Home and Community Services segment.
Executives
David Pierre officer: Chief Operating Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Paymon Farazi officer: Chief Product Officer C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Tim Gronniger officer: Ch. Value-Based Sols. Off C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Vivian E. Riefberg director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Adam Mcananey officer: General Counsel and Secretary 800 CONNECTICUT AVENUE, NORWALK CT 06854
Marc D Rothman officer: Chief Medical Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Kyle B. Peterson director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Taj J. Clayton director 800 CONNECTICUT AVENUE, NORWALK CT 06854
Josh Builder officer: Chief Technology Officer 800 CONNECTICUT AVENUE, NORWALK CT 06854
Heather Brianne Dixon director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Steve Senneff officer: Pres. Chief Fin. & Admin. Off. C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Bradford Kyle Armbrester director, officer: Chief Executive Officer 311 ARSENAL STREET, WATERTOWN MA 02472
Albert A Notini director C/O DELTEK, INC., 2291 WOOD OAK DRIVE, HERNDON VA 20171
Kevin M Mcnamara director 2200 DON TYSON PARKWAY, SPRINGDALE AR 72762
Matthew S. Holt director C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019